Asset Publisher
Research on COVID drug from plants
Ö1 radio report – 16. Feb 2022
Will the next COVID drug be produced in plants?
Interview on a novel approach with Kurt Zatloukal, BBMRI.at Director
| Research on COVID drug from plants
Sars-CoV-2, the corona virus, that triggered the current pandemic, will remain. Practically all researchers are currently assuming this. Consequently also the disease COVID will remain and, therefore, medication will be needed to counteract it.
An international team of researchers from Med Uni Graz, University of Natural Resources and Life Sciences Vienna and a company from South Africa is pursuing an exciting approach to develop a COVID drug made from plants.
More in the radio report (available in German only)>
Radio report from the EU-Africa summit in Brussels (16 Feb 2022) with BBMRI.at Director Kurt Zatloukal (pathologist at the Medical University of Graz); Josef Glößl, cell biologist at the University of Natural Resources and Life Sciences in Vienna
Design: Robert Zikmund
|
Image: Ö1 |
